More preventive treatment options needed, researchers say

More preventive treatment options needed, researchers say

Prophylactic (preventive) treatment for hemophilia A and B is generally more effective than on-demand treatment in reducing the frequency of bleeding, but the benefit is not as clear in patients who have developed inhibitors that limit how well replacement clotting factors work. That’s according to real-world data from explorer6 (NCT03741881), a non-interventional study sponsored by Novo Nordisk that ran across 33 countries. The study followed p…